SUN PHARMACEUTICAL INDUSTRIES
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Income Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹58,462 Cr | ₹52,578 Cr | ₹48,497 Cr | ₹43,886 Cr | ₹67,191 Cr |
| Sales | ₹56,840 Cr | ₹51,478 Cr | ₹47,130 Cr | ₹42,785 Cr | ₹66,963 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹1,380 Cr | ₹563 Cr | ₹628 Cr | ₹494 Cr | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹242 Cr | ₹537 Cr | ₹738 Cr | ₹607 Cr | ₹228 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹58,462 Cr | ₹52,578 Cr | ₹48,497 Cr | ₹43,886 Cr | ₹38,654 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹343 Cr | ₹150 Cr | ₹292 Cr | ₹-687 Cr | ₹-108 Cr |
| Raw Material Consumed | ₹11,201 Cr | ₹10,597 Cr | ₹10,370 Cr | ₹11,349 Cr | ₹10,459 Cr |
| Opening Raw Materials | ₹3,436 Cr | ₹3,130 Cr | ₹3,478 Cr | ₹2,914 Cr | ₹3,344 Cr |
| Purchases Raw Materials | ₹8,132 Cr | ₹6,756 Cr | ₹6,555 Cr | ₹8,342 Cr | ₹6,618 Cr |
| Closing Raw Materials | ₹4,179 Cr | ₹3,436 Cr | ₹3,130 Cr | ₹3,478 Cr | ₹2,914 Cr |
| Other Direct Purchases / Brought in cost | ₹3,812 Cr | ₹4,148 Cr | ₹3,466 Cr | ₹3,572 Cr | ₹3,410 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹814 Cr | ₹750 Cr | ₹761 Cr | ₹830 Cr | ₹703 Cr |
| Electricity & Power | ₹814 Cr | ₹750 Cr | ₹761 Cr | ₹830 Cr | ₹703 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹11,419 Cr | ₹9,973 Cr | ₹9,429 Cr | ₹8,296 Cr | ₹7,301 Cr |
| Salaries, Wages & Bonus | ₹10,059 Cr | ₹8,818 Cr | ₹8,331 Cr | ₹7,340 Cr | ₹6,444 Cr |
| Contributions to EPF & Pension Funds | ₹658 Cr | ₹570 Cr | ₹529 Cr | ₹514 Cr | ₹469 Cr |
| Workmen and Staff Welfare Expenses | ₹580 Cr | ₹498 Cr | ₹497 Cr | ₹378 Cr | ₹336 Cr |
| Other Employees Cost | ₹122 Cr | ₹87 Cr | ₹72 Cr | ₹63 Cr | ₹52 Cr |
| Other Manufacturing Expenses | ₹2,564 Cr | ₹2,261 Cr | ₹2,187 Cr | ₹1,937 Cr | ₹1,881 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹667 Cr | ₹624 Cr | ₹630 Cr | ₹561 Cr | ₹558 Cr |
| Repairs and Maintenance | ₹935 Cr | ₹811 Cr | ₹780 Cr | ₹657 Cr | ₹525 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹962 Cr | ₹826 Cr | ₹777 Cr | ₹719 Cr | ₹798 Cr |
| General and Administration Expenses | ₹6,083 Cr | ₹5,646 Cr | ₹5,253 Cr | ₹4,256 Cr | ₹3,271 Cr |
| Rent , Rates & Taxes | ₹1,104 Cr | ₹823 Cr | ₹827 Cr | ₹729 Cr | ₹649 Cr |
| Insurance | ₹319 Cr | ₹327 Cr | ₹304 Cr | ₹299 Cr | ₹262 Cr |
| Printing and stationery | ₹215 Cr | ₹189 Cr | ₹171 Cr | ₹67 Cr | ₹61 Cr |
| Professional and legal fees | ₹3,259 Cr | ₹3,261 Cr | ₹2,953 Cr | ₹2,312 Cr | ₹1,803 Cr |
| Traveling and conveyance | ₹1,034 Cr | ₹911 Cr | ₹818 Cr | ₹642 Cr | ₹374 Cr |
| Other Administration | ₹151 Cr | ₹135 Cr | ₹180 Cr | ₹207 Cr | ₹122 Cr |
| Selling and Distribution Expenses | ₹7,748 Cr | ₹6,577 Cr | ₹5,780 Cr | ₹5,226 Cr | ₹4,096 Cr |
| Advertisement & Sales Promotion | - | - | - | - | - |
| Sales Commissions & Incentives | ₹199 Cr | ₹211 Cr | ₹223 Cr | ₹207 Cr | ₹195 Cr |
| Freight and Forwarding | ₹939 Cr | ₹906 Cr | ₹812 Cr | ₹934 Cr | ₹793 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | ₹6,611 Cr | ₹5,460 Cr | ₹4,744 Cr | ₹4,085 Cr | ₹3,108 Cr |
| Miscellaneous Expenses | ₹1,799 Cr | ₹1,537 Cr | ₹1,676 Cr | ₹1,091 Cr | ₹1,170 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | ₹63 Cr | ₹181 Cr | ₹91 Cr | ₹43 Cr | ₹18 Cr |
| Losson disposal of fixed assets(net) | ₹9.61 Cr | ₹6.55 Cr | ₹31 Cr | ₹3.65 Cr | ₹14 Cr |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹1,726 Cr | ₹1,350 Cr | ₹1,554 Cr | ₹1,044 Cr | ₹1,139 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹41,971 Cr | ₹37,492 Cr | ₹35,748 Cr | ₹32,298 Cr | ₹28,773 Cr |
| Operating Profit (Excl OI) | ₹16,491 Cr | ₹15,086 Cr | ₹12,749 Cr | ₹11,588 Cr | ₹9,882 Cr |
| Other Income | ₹3,212 Cr | ₹2,151 Cr | ₹1,628 Cr | ₹694 Cr | ₹1,437 Cr |
| Interest Received | ₹915 Cr | ₹1,230 Cr | ₹1,023 Cr | ₹385 Cr | ₹553 Cr |
| Dividend Received | ₹59 Cr | ₹67 Cr | ₹103 Cr | ₹146 Cr | ₹215 Cr |
| Profit on sale of Fixed Assets | ₹3.16 Cr | ₹12 Cr | ₹21 Cr | ₹11 Cr | ₹49 Cr |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | ₹0.32 Cr | ₹5.62 Cr | ₹29 Cr | ₹15 Cr | ₹5.98 Cr |
| Foreign Exchange Gains | ₹1,240 Cr | ₹186 Cr | ₹36 Cr | ₹-126 Cr | ₹154 Cr |
| Others | ₹994 Cr | ₹650 Cr | ₹416 Cr | ₹263 Cr | ₹460 Cr |
| Operating Profit | ₹19,703 Cr | ₹17,237 Cr | ₹14,377 Cr | ₹12,281 Cr | ₹11,319 Cr |
| Interest | ₹339 Cr | ₹231 Cr | ₹238 Cr | ₹172 Cr | ₹127 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | - | - | - | - | - |
| Other Interest | ₹339 Cr | ₹231 Cr | ₹238 Cr | ₹172 Cr | ₹127 Cr |
| PBDT | ₹19,364 Cr | ₹17,005 Cr | ₹14,139 Cr | ₹12,109 Cr | ₹11,192 Cr |
| Depreciation | ₹2,938 Cr | ₹2,575 Cr | ₹2,557 Cr | ₹2,529 Cr | ₹2,144 Cr |
| Profit Before Taxation & Exceptional Items | ₹16,426 Cr | ₹14,430 Cr | ₹11,582 Cr | ₹9,580 Cr | ₹9,048 Cr |
| Exceptional Income / Expenses | ₹-1,307 Cr | ₹-678 Cr | ₹-494 Cr | ₹-171 Cr | ₹-4,567 Cr |
| Profit Before Tax | ₹15,119 Cr | ₹13,752 Cr | ₹11,088 Cr | ₹9,408 Cr | ₹4,481 Cr |
| Provision for Tax | ₹3,554 Cr | ₹2,772 Cr | ₹1,439 Cr | ₹848 Cr | ₹1,076 Cr |
| Current Income Tax | ₹4,198 Cr | ₹3,320 Cr | ₹1,989 Cr | ₹1,869 Cr | ₹354 Cr |
| Deferred Tax | ₹-643 Cr | ₹-548 Cr | ₹-550 Cr | ₹-1,022 Cr | ₹721 Cr |
| Other taxes | - | - | - | - | - |
| Profit After Tax | ₹11,565 Cr | ₹10,980 Cr | ₹9,648 Cr | ₹8,561 Cr | ₹3,406 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | ₹-29 Cr | ₹-36 Cr | ₹-34 Cr | ₹-39 Cr | ₹-117 Cr |
| Share of Associate | ₹-56 Cr | ₹-15 Cr | ₹-38 Cr | ₹-48 Cr | ₹-17 Cr |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹11,479 Cr | ₹10,929 Cr | ₹9,576 Cr | ₹8,474 Cr | ₹3,273 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹57,862 Cr | ₹50,155 Cr | ₹43,610 Cr | ₹37,646 Cr | ₹36,598 Cr |
| Appropriations | ₹69,341 Cr | ₹61,084 Cr | ₹53,187 Cr | ₹46,119 Cr | ₹39,871 Cr |
| General Reserves | ₹-3,478 Cr | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹850 Cr | ₹807 Cr | ₹1,094 Cr | ₹709 Cr | ₹546 Cr |
| Equity Dividend % | ₹1,600.00 | ₹1,600.00 | ₹1,350.00 | ₹1,150.00 | ₹1,000.00 |
| Earnings Per Share | ₹47.84 | ₹45.55 | ₹39.91 | ₹35.32 | ₹13.64 |
| Adjusted EPS | ₹47.84 | ₹45.55 | ₹39.91 | ₹35.32 | ₹13.64 |
Compare Income Statement of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,975.8 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
| MANKIND PHARMA | ₹102,795.0 Cr | 0.1% | 5.5% | 10.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.9% |
5.6% |
14.1% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses